Publications found:
705
Sort by:
Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, VEGF/VEGFR Inhibitors, PARP Inhibitors, Antineoplastics, Others), By Tumor Type (Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumor, Germ Cell Tumor, Sex Cord-Stromal Tumor), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Ovarian Cancer Drugs Market will grow from USD 4.32 Billion in 2025 to USD 6.36 Billion by 2031 at a 6.66% CAGR. Ovarian cancer drugs encompass a diverse range of pharmacological interventi...
January 2026
181 pages
Brain Tumor Drugs Market - Forecast from 2026 to 2031
US$ 3,950.00
The brain tumor drugs market, growing at a 7.36% CAGR, is anticipated to reach USD 4.276 billion in 2031 from USD 2.792 billion in 2025. The brain tumor drugs market is a critical and high-stakes segm...
January 2026
149 pages
Global Oncology Biosimilars Market
US$ 4,650.00
: The global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6%...
December 2025
173 pages
Cancer Immunotherapy Market Size, Share & Trends Analysis Report By Product (Monoclonal Antibodies, Immunomodulators), By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new ... number of approvals for new immunotherapeutic drugs is driving the global market. Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical ...
December 2025
150 pages
Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Immunotherapy), By Route Of Administration, By Distribution Channel (Hospital Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... , radiation therapy, chemotherapy, and immunotherapy in the head and neck cancer therapeutics market. Major challenges faced by this patient population ... drug delivery approaches to improve overall survival rates Among EU5, Germany captured the top position in the global head and neck cancer therapeutics ...
December 2025
150 pages
Keytruda Market Size, Share & Trends Analysis Report By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global Keytruda market size was estimated at USD 31.38 billion in 2025 and is projected to reach USD 24.95 billion by 2033, declining at a CAGR of -3.80% from 2026 to 2033. The market outlook for...
December 2025
150 pages
Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedures (Tumor Biopsy, Vascular Interventions), By Application (Lung Cancer, Kidney Cancer), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global interventional oncology market size was estimated at USD 2.90 billion in 2025 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 8.59% from 2026 to 2033. This growth...
December 2025
210 pages
Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration), By End Users (Hospitals & Clinics, Ambulatory Care centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anti-Vascular Endothelial Growth Factor Therapeutics Market, valued at USD 14.38 Billion in 2024, is projected to experience a CAGR of 3.65% to reach USD 17.83 Billion by 2030. Anti-vascula...
December 2025
185 pages
Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Aggressive CLL, Indolent CLL, Others), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route of Administration (Oral, Parental, Others), By End user (Hospital, Diagnostic Laboratories, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Chronic Lymphocytic Leukemia Treatment Market will grow from USD 13.37 Billion in 2024 to USD 21.51 Billion by 2030 at a 8.25% CAGR. The global chronic lymphocytic leukemia (CLL) treatment...
December 2025
185 pages
Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy), By Disease Type (Superficial Spreading Melanoma, Lentigo Maligna, Acral Lentiginous Melanoma, Nodular Melanoma), By Application (Hospitals, Outpatient Oncologist Clinics, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Melanoma Drugs Market will grow from USD 7.42 Billion in 2024 to USD 11.98 Billion by 2030 at a 8.31% CAGR. Melanoma drugs refer to pharmaceutical agents developed to treat melanoma, an agg...
December 2025
185 pages
Myeloproliferative Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Hyper eosinophilic Syndrome, Systemic Masto cytosis), By Drug Type (JAK2 Inhibitors, Anti-Neoplastic, Demethylation Agents, Imatinib Mesylate, Others), By Route of Administration (Oral, Parental, Others), By Distribution Channel (Hospital Pharmacy, Retail Stores, Drug Stores), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Myeloproliferative Disorders Drugs Market will grow from USD 9.94 Billion in 2024 to USD 14.06 Billion by 2030 at a 5.95% CAGR. Myeloproliferative Disorders (MPDs) drugs comprise a speciali...
December 2025
185 pages
Tyrosine Kinase Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Other), By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Other), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Tyrosine Kinase Inhibitors Market will grow from USD 52.07 Billion in 2024 to USD 83.09 Billion by 2030 at a 8.10% CAGR. Tyrosine Kinase Inhibitors, or TKIs, are a class of pharmaceutical d...
December 2025
183 pages
Angiosarcoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma), By Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others), By End user (Hospital & Clinics, Ambulatory Surgical Centers, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a ra...
December 2025
180 pages
Precision Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Precision Oncology Market , valued at USD 99.45 Billion in 2024, is projected to experience a CAGR of 9.12% to reach USD 167.87 Billion by 2030. Precision oncology tailors cancer treatment...
December 2025
183 pages
Acute Myeloid Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, hormonal therapy, and other chemotherapies), By Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Acute Myeloid Leukemia Market, valued at USD 1.56 Billion in 2024, is projected to experience a CAGR of 8.90% to reach USD 2.63 Billion by 2030. Acute Myeloid Leukemia (AML) is a rapidly pr...
December 2025
183 pages
Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Hormonal Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), By Cancer Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global breast cancer drugs market size was estimated at USD 36.62 billion in 2024 and is projected to reach USD 69.72 billion by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market is...
December 2025
150 pages
Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (B-cell Lymphomas, T-cell Lymphoma), By Drug Class (Monoclonal Antibodies, Antibody-Drug Conjugates, BTK/BCL-2 Kinase Inhibitors, PI3 Kinase Inhibitors, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma Market, valued at USD 7.24 Billion in 2024, is projected to experience a CAGR of 7.72% to reach USD 11.31 Billion by 2030. The global Non-Hodgkin Lymphoma market compri...
November 2025
187 pages
Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Breast Cancer, Blood Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Lung Cancer, Others), By Drug (Cytotoxic, Hormonal Therapy, Targeted Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anticancer Drug Market, valued at USD 179.93 Billion in 2024, is projected to experience a CAGR of 5.25% to reach USD 244.59 Billion by 2030. Anticancer drugs represent pharmaceutical agent...
November 2025
185 pages
Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Type of Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Stem Cell Transplant, Others), By Cell Type (B-cell Lymphomas, T-cell Lymphomas), By Drug Type (Revlimid, Rituxan, Keytruda, Imbruvica, Opdivo, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 4,500.00
The Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market , valued at USD 8.19 Billion in 2024, is projected to experience a CAGR of 7.61% to reach USD 12.72 Billion by 2030. Non-Hodgkin Lymphoma (NHL...
November 2025
180 pages
Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Oncology Drugs Market, valued at USD 228.65 Billion in 2024, is projected to experience a CAGR of 13.33% to reach USD 484.54 Billion by 2030. Oncology drugs are pharmaceutical agents develo...
November 2025
185 pages
Cancer Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Application (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, Others)
US$ 3,950.00
The Cancer Drugs Market is valued at USD 267 billion in 2025 and is projected to grow at a CAGR of 14.3% to reach USD 889.1 billion by 2034. Cancer Drugs Market The Cancer Drugs Market encompasses tar...
November 2025
160 pages
CAR T cell Therapy Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease Indication (Leukemia, Lymphoma, Multiple Myeloma, Others), By End-User
US$ 3,950.00
The CAR T cell Therapy Market is valued at USD 5.72 billion in 2025 and is projected to grow at a CAGR of 28% to reach USD 52.76 billion by 2034. CAR T cell Therapy Market CAR?T cell therapy refers to...
November 2025
160 pages
Keytruda Market Outlook 2026-2034: Market Share, and Growth Analysis By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma, Head and Neck Cancer, Gastric Cancer, Urothelial Cancer, Others), By Payer (Commercial/Private, Public), By Distribution Channel
US$ 3,950.00
The Keytruda Market is valued at USD 29.87 billion in 2025 and is projected to grow at a CAGR of 9% to reach USD 64.87 billion by 2034. Keytruda Market Keytruda (pembrolizumab) has evolved into a corn...
November 2025
160 pages
